Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
18-Mar-2012 | News-Press Release
Where are antithrombotic and anticoagulant treatments heading? Visiongain's  report shows you potential revenues to 2022, with data, forecasts and  discussions.
  
  This study assesses drugs to treat abnormal blood clotting in human beings.  Discover sales predictions at world market, therapeutic class, product and  national levels to 2022.  http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/antithrombotic-anticoagulant-drugs-world-market-2012-2022.html
  
  How will products - Plavix, Lovenox, Pletal, Fragmin, Asasantin, Arixtra,  Aspirin Cardio, Effient, Pradaxa, Brilinta and others - perform? Our report  gives you business research and analysis with many sales predictions. See the  future of the industry and market. Marketing  Research Companies
  
  Also, receive forecasting of submarkets, finding potential sales trends from  2012: 
  • Platelet aggregation inhibitors
  • Heparins
  • Fibrinolytics
  • Vitamin K antagonists
  • Direct thrombin inhibitors
  • Direct factor Xa inhibitors.
  
  Our report discusses activities of Eli Lilly, Boehringer Ingelheim, AstraZeneca,  J&J, Bayer, Sanofi, Merck, Eisai, Daiichi Sankyo and other pharmaceutical  companies. 
  
  What does the future hold? With its R&D pipelines, the pharma industry has  potential for improved treatments and increased revenues from blood-thinning  agents. Many commercial opportunities remain. 
  
  Worldwide, numbers of heart attacks and strokes will rise this decade. Blood  thinners will play important roles in medicine, helping to prevent and treat  cardiovascular disorders.
  
  Visiongain's study provides data, analysis and opinion aiming to benefit your  research, calculations, meetings and presentations. You will find answers in our  work.
  
  Revenue forecasts, market shares, developmental trends, discussions and  interviews
  In the report you find revenue forecasting, growth rates, market shares,  qualitative analyses (including SWOT and STEP), opinions and R&D news. You  receive 82 tables and charts and four research interviews.
  
  Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for  your work
  In particular, this study gives you the following knowledge and benefits:
  • Find revenue predictions to 2022 for the overall world market and submarkets
  • Discover revenue forecasts to 2022 for 14 drugs, assessing commercial  potential
  • See revenue forecasts to 2022 for leading national markets - US, Japan,  Germany, France, UK, Spain, Italy, China and India
  • Assess leading companies, discovering activities and outlooks
  • Review R&D, seeing pipeline trends
  • Investigate competition and opportunities influencing sales results
  • Find out what will stimulate and restrain the industry and market
  • View opinions from our survey of authorities on the sector.
  
  For more information kindly visit : 
  Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
  
  Or
  
  Bharat Book Bureau
  Tel: +91 22 27810772 / 27810773
  Fax: + 91 22 27812290
  Email: info@bharatbook.com
  Website: www.bharatbook.com
  Follow us on twitter:  http://twitter.com/#!/Sandhya3B
This release was submitted by a Newsbox user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Research on Global and China Epoxy Resin Industry Chain Report
 - The Geothermal Energy Market 2012-2022
 - Adhesives and Sealants: Global Markets
 - Dermatological Drugs: World Market Prospects 2012-2022
 - The Electric and Range Extended Electric Light-Vehicle Report
 - India Urban & Industrial Waste to Energy Market
 - Understanding Russia's Regional Health Markets
 - 2012 Deep Research Report on China Wind Bearing Industry
 - Top 1000 Advertising Agents (European)
 - HNWI Asset Allocation in Switzerland to 2016
 
		


